We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+14.96%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$627M
AUM Growth
+$181M
Cap. Flow
+$130M
Cap. Flow %
20.82%
Top 10 Hldgs %
46.99%
Holding
210
New
76
Increased
33
Reduced
30
Closed
60

Sector Composition

Rank Sector Weight
1 Technology 23.98%
2 Healthcare 15.11%
3 Industrials 12.05%
4 Consumer Discretionary 6.3%
5 Consumer Staples 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTE
201
CALL
DELISTED
PolarityTE, Inc. Common Stock
PTE
-1,000
Closed -$81K
PTE
202
DELISTED
PolarityTE, Inc. Common Stock
PTE
-33,610
Closed -$2.71M
XLNX
203
CALL
DELISTED
Xilinx Inc
XLNX
-10,000
Closed -$959K
XLNX
204
DELISTED
Xilinx Inc
XLNX
-5,000
Closed -$480K
CLDR
205
DELISTED
Cloudera, Inc.
CLDR
-541,000
Closed -$4.8M
ALXN
206
DELISTED
Alexion Pharmaceuticals
ALXN
-2,500
Closed -$245K
WORK
207
PUT
DELISTED
Slack Technologies, Inc.
WORK
-60,000
Closed -$1.42M
PRAH
208
DELISTED
PRA Health Sciences, Inc.
PRAH
-6,000
Closed -$595K
CORV
209
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
-12,500
Closed -$25K
NVTR
210
DELISTED
Nuvectra Corporation Common Stock
NVTR
-25,095
Closed -$34K

Similar funds

Ardsley Advisory Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Ardsley Advisory Partners held 210 positions worth $627M, up 41% from $446M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Ardsley Advisory Partners deployed $130M of net new capital in Q4 2019, opening 76 new positions and adding to 33 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 110,000 shares worth $10.5M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 29% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Walt Disney, an estimated $10.6M trimmed.

  • Ardsley Advisory Partners's largest Q4 2019 buy was State Street SPDR S&P Biotech ETF: 110,000 shares worth $10.5M.
  • Ardsley Advisory Partners added most to Guardant Health in Q4 2019, an estimated $17.7M increase.
  • Ardsley Advisory Partners's biggest Q4 2019 reduction was Walt Disney, cutting an estimated $10.6M.
  • Ardsley Advisory Partners fully exited Medifast in Q4 2019, selling an estimated $9.84M.
  • Ardsley Advisory Partners's ten largest holdings make up 47% of its $627M portfolio in Q4 2019.
  • Ardsley Advisory Partners opened 76 new positions and closed 60 in Q4 2019.
  • Ardsley Advisory Partners's portfolio value rose 41% quarter-over-quarter to $627M.

Based on Ardsley Advisory Partners's 13F filing for Q4 2019, filed 14 Feb 2020.